Validation of a direct agglutination test prototype kit for the diagnosis of visceral leishmaniasis

Trans R Soc Trop Med Hyg. 2013 Apr;107(4):243-7. doi: 10.1093/trstmh/trt004. Epub 2013 Feb 3.

Abstract

Background: A freeze-dried antigen was developed with Leishmania (L.) infantum and used for the production of a prototype direct agglutination test kit for the laboratory diagnosis of visceral leishmaniasis (VL), called DAT-LPC. On this study the diagnosis validity of this prototype was performed.

Methods: To evaluate the sensitivity and specificity 103 samples from Brazilian patients with VL and 110 samples from patients with other parasitic infections, and healthy subjects were assayed with DAT-LPC and DAT-KIT (Royal Tropical Institute, Amsterdam, NL). Additionally, the results of 103 samples of VL patients based on two agglutination tests were transformed in Log10 and correlated.

Results: The DAT-LPC showed a sensitivity of 99.0%, specificity of 98.2% and diagnosis validity of 98.6%, which were similar to those found by the DAT-KIT (p > 0.05). Moreover, there was positive correlation between the positive titers obtained by DAT-LPC and by DAT-KIT (Spearman correlation coefficient of 0.75 p = 0.0001).

Conclusions: DAT-LPC showed thermal stability and diagnosis performance similar to those of the DAT-KIT. Our results suggest that DAT-LPC is a robust, simple, equipment-independent and efficient tool for the diagnosis of VL and should thus replace the IFAT as routine diagnostic test in the Brazilian public health system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Agglutination Tests / methods*
  • Antibodies, Protozoan / analysis
  • Brazil
  • Humans
  • Leishmania infantum / immunology
  • Leishmaniasis, Visceral / diagnosis*
  • Reagent Kits, Diagnostic
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Antibodies, Protozoan
  • Reagent Kits, Diagnostic